YorLabs Receives FDA Clearance for Zero-CapEx Intracardiac Imaging System
YorLabs has received U.S. Food and Drug Administration 510(k) clearance for its Intracardiac Imaging System, announced in a press release. The zero-capex ultrasound platform is designed to simplify workflow and reduce costs in electrophysiology and interventional cardiology procedures.
The system provides high-resolution, real-time imaging and allows single-operator control for a variety of intracardiac procedures. It integrates wirelessly into existing catheterization labs, enabling flexible deployment without requiring major equipment investments.
YorLabs said it plans a limited U.S. market release in 2026, followed by broader commercial rollout and clinical collaborations with leading centers in electrophysiology and interventional cardiology.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
AIRS Medical Gets FDA Clearance for MRI Body Composition Tool
RIVANNA Files 100th Patent for Ultrasound AI
Taiwanese Health Technology Groups Test US Market in Dallas
AnX Robotica Cites 88.6% ProScan Review Time Reduction
Rhythm AI Study Reports 90% Freedom From Atrial Fibrillation
Daily AI Brief: the AI news that matters, in your inbox.